Literature DB >> 17195039

[Mediastinal large B-cell lymphoma].

T F E Barth1, P Möller.   

Abstract

Mediastinal B-cell lymphoma is a locally highly aggressive tumour which was first described in the early 1980s. The incidence is about 2-3% of all non-Hodgkin's lymphomas. The conceptional evolution of this lymphoma entity was hampered by its low incidence and the broad spectrum of morphological variants present. However, since mediastinal B-cell lymphoma has distinct morphological, immunological, genetic, and clinical features, it has been listed in the revised European-American Classification of Lymphoid Neoplasms (REAL-Classification) since 1994 as a variant of diffuse large B-cell lymphoma. In the World Health Organization classification of malignant lymphomas, mediastinal B-cell lymphoma is now listed with an own disease code (ICD-9679/3).

Entities:  

Mesh:

Year:  2007        PMID: 17195039     DOI: 10.1007/s00292-006-0880-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  44 in total

1.  Immunophenotypic similarities of mediastinal clear-cell lymphoma and sinusoidal (monocytoid) B cells.

Authors:  P Möller; D U Matthaei-Maurer; W J Hofmann; B Dörken; G Moldenhauer
Journal:  Int J Cancer       Date:  1989-01-15       Impact factor: 7.396

2.  Primary mediastinal clear cell lymphoma of B-cell type.

Authors:  P Möller; B Lämmler; M Eberlein-Gonska; G E Feichter; W J Hofmann; H Schmitteckert; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases.

Authors:  F Menestrina; M Chilosi; F Bonetti; M Lestani; A Scarpa; P Novelli; C Doglioni; G Todeschini; A Ambrosetti; L Fiore-Donati
Journal:  Histopathology       Date:  1986-06       Impact factor: 5.087

4.  Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?

Authors:  L de Leval; J A Ferry; B Falini; M Shipp; N L Harris
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

5.  Molecular characterization of primary mediastinal B cell lymphoma.

Authors:  P Tsang; E Cesarman; A Chadburn; Y F Liu; D M Knowles
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Authors:  Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

7.  Primary mediastinal non-Hodgkin's lymphomas: a morphologic and immunologic study of 19 cases.

Authors:  S A Yousem; L M Weiss; R A Warnke
Journal:  Am J Clin Pathol       Date:  1985-06       Impact factor: 2.493

8.  Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas.

Authors:  P Kanavaros; P Gaulard; F Charlotte; N Martin; C Ducos; M Lebezu; D Y Mason
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

9.  Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma.

Authors:  M A Weniger; K Pulford; S Gesk; S Ehrlich; A H Banham; L Lyne; J I Martin-Subero; R Siebert; M J S Dyer; P Möller; T F E Barth
Journal:  Leukemia       Date:  2006-07-27       Impact factor: 11.528

10.  Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.

Authors:  Andreas Rosenwald; George Wright; Karen Leroy; Xin Yu; Philippe Gaulard; Randy D Gascoyne; Wing C Chan; Tong Zhao; Corinne Haioun; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Elias Campo; Emili Montserrat; Armando Lopez-Guillermo; German Ott; H Konrad Muller-Hermelink; Joseph M Connors; Rita Braziel; Thomas M Grogan; Richard I Fisher; Thomas P Miller; Michael LeBlanc; Michael Chiorazzi; Hong Zhao; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Louis M Staudt
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.